BOURKOULA, Evgenia
 Distribuzione geografica
Continente #
NA - Nord America 411
EU - Europa 129
AS - Asia 50
SA - Sud America 1
Totale 591
Nazione #
US - Stati Uniti d'America 409
IT - Italia 41
UA - Ucraina 33
CN - Cina 19
DE - Germania 18
VN - Vietnam 16
SE - Svezia 13
IE - Irlanda 6
TR - Turchia 6
FI - Finlandia 5
GB - Regno Unito 4
IN - India 4
SG - Singapore 4
BE - Belgio 3
RU - Federazione Russa 3
CA - Canada 2
PL - Polonia 2
BR - Brasile 1
FR - Francia 1
IR - Iran 1
Totale 591
Città #
Fairfield 69
Chandler 41
Woodbridge 41
Ashburn 34
Houston 22
Ann Arbor 21
Udine 21
Dearborn 20
Seattle 18
Wilmington 17
Cambridge 16
Dong Ket 16
Jacksonville 16
Boardman 9
Des Moines 6
Dublin 6
Izmir 6
Princeton 6
Hefei 5
Beijing 4
Cagliari 4
Brussels 3
Kunming 3
Phoenix 3
San Diego 3
Singapore 3
Boulder 2
Nanjing 2
New York 2
Norwalk 2
Ottawa 2
Trieste 2
Warsaw 2
Chengdu 1
Crick 1
Fano 1
Fuzhou 1
Grafing 1
Helsinki 1
Kashan 1
Monfalcone 1
Nanchang 1
Ogden 1
Pordenone 1
San Mateo 1
Shaoxing 1
Vila Velha 1
Totale 441
Nome #
Systemic T cells immunosuppression of glioma stem cell-derived exosomes is mediated by monocytic myeloid-derived suppressor cells 126
Topoisomerase IIβ mediates the resistance of glioblastoma stem cells to replication stress-inducing drugs 123
Glioma Associated Stem Cells (GASCs) Isolation and Culture. 112
A NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells 112
TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers. 96
ISOLATION AND CHARACTERIZATION OF STEM CELLS ISOLATED FROM HUMAN LOW-GRADE AND HIGH-GRADE GLIOMAS 52
Totale 621
Categoria #
all - tutte 1.782
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.782


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020170 0 0 7 28 16 36 26 17 10 12 6 12
2020/2021124 10 8 4 9 5 16 3 12 13 12 9 23
2021/202262 3 5 6 4 0 1 5 1 1 10 17 9
2022/202381 9 10 2 12 7 25 0 2 11 1 0 2
2023/202428 4 1 0 0 3 4 0 11 2 0 1 2
2024/20258 2 6 0 0 0 0 0 0 0 0 0 0
Totale 621